Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Topical minoxidil effectively prevents tissue death in certain surgeries.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.